Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Infosys Share Price Live Updates: AI prescription: Infosys bags seven-year deal to upgrade Fortis-owner IHH's network
Stocks to buy in 2026 for long term: Suzlon, Fortis Healthcare among 5 stocks that could give 10-60% returns
We have collated a list of recommendations from top brokerage firms from ETNow and other sources.
After 50 hearings, court reserves judgement in Daiichi-Fortis case
The Delhi High Court has reserved its judgment in a significant arbitration case. Japanese drug maker Daiichi Sankyo is seeking to enforce a decade-old award of ₹5,200 crore against former Fortis promoters. The case involves allegations of fraud in the sale of Ranbaxy Laboratories. Daiichi aims to recover its dues, while Fortis disputes liability for shrinking assets.
Six pharma stocks that should be on your radar today over various news triggers
It was a busy weekend for pharma stocks as four of them — Divi's Laboratories, Fortis Healthcare, Torrent Pharma and Narayana Hrudayalaya — reported their quarterly results. Meanwhile, Lupin marked its entry into the Chinese market, while Glenmark Pharma's US arm settled an anti-trust litigation. Here's a look at these names in detail:
Fortis Healthcare consolidated net profit rises 44.57% in the March 2026 quarter
Sales rise 17.81% to Rs 2364.67 crore
Fortis liability case: Delhi HC says blame can't be shifted to third party
Amid ongoing legal disputes, the Delhi High Court is probing Fortis Healthcare's oversight concerning the sale of shares belonging to the Singh brothers, former promoters of the company. The court's remarks suggest that Fortis had a responsibility to inhibit such transactions.
Fortis Healthcare Q4 profit up 45% on lower exceptional losses, higher revenue
The board recommended a final dividend of ₹1 per equity share of face value ₹10 each for FY26. Shares of Fortis Healthcare Limited ended ₹5.40 lower at ₹961.90 on the NSE today, May 22.
Q4 Results Live Updates: Sun Pharma Revenue Up 12%; IRCON Profit Falls 10%
Key companies in focus include Sun Pharma, NTPC Green Energy, Hindalco Industries, Eicher Motors, Colgate-Palmolive (India), Fortis Healthcare and 3M India.
Q4 Results LIVE Updates: Max Health shares decline 7%, Honasa Consumer up 7%; Hindalco report today
Q4 Results Live Update: Another busy earnings week ends with three Nifty names - Sun Pharma, Eicher Motors and Hindalco reporting their results today, along with broader market names like Torrent Pharma, Fortis Healthcare, DAM Capital, Colgate-Palmolive, IRCON International, Jubilant Pharmova, Minda Corp, and many others. LG, LIC, GAIL, ITC, will also be reacting to their results reported on Thursday.
Fortis Malar Hospitals reports consolidated net loss of Rs 0.05 crore in the March 2026 quarter
Reported sales nil
Stocks to buy for short term: Bharat Forge, Fortis Health - Ajit Mishra of Religare Broking suggests 3 stock picks
Ajit Mishra from Religare Broking identifies three stocks, including Bharat Forge and Fortis Healthcare, that show promise for short-term investors. With strategic breakouts and bullish patterns, these stocks could offer lucrative opportunities despite current market pressures.
IHH Healthcare aims to hike its stake in Fortis to 50%: CEO Prem Kumar Nair
IHH Healthcare sees India as a major growth market. The company plans to increase its stake in Fortis Healthcare. IHH aims to expand its hospital bed count to 10,000 by 2030. Investments will focus on existing Fortis locations and integrating Gleneagles facilities. The group is also repositioning its diagnostics arm.